Multiple Myeloma: Belantamab Mafodotin vs. Daratumumab

We are studying a new treatment combination for people with newly diagnosed multiple myeloma who cannot have stem cell transplants. The goal is to see if it works better and is safer than the current standard treatment.

11-15 visits Confirmation phase (III)Post-Trial Drug Access No Placebo Cost Reimbursement Partially Remote Investigational Medicines Oral InjectionHematologyOncology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Darzalex

Darzalex is a medicine used to treat multiple myeloma, a type of blood cancer.

Dexamethason Galen

Dexamethason Galen is a steroid medicine used to reduce inflammation and treat severe allergies or immune-related conditions.

Dexamethason Jenapharm

Dexamethason Jenapharm is a medicine that reduces swelling and eases allergic or immune reactions and other serious health problems.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Daratumumab

Daratumumab is a substance that helps treat multiple myeloma, a blood cancer, by directing the immune system to attack the cancerous plasma cells.

Dexamethasone

Dexamethasone is a steroid that reduces inflammation and suppresses the immune system to treat allergic, inflammatory, and autoimmune conditions.

Dexamethasone Disodium Phosphate

Dexamethasone disodium phosphate is a corticosteroid substance that reduces inflammation and suppresses the immune response.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Belantamab mafodotin

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

7,5 Mg Stada

Aacidexam

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Ordensklinikum Linz GmbH

Interne 1 - Hämatologie mit Stammzellentransplantation, Hämostaseologie und medizinische Onkologie

Linz, Austria

SCRI CCCIT Ges.m.b.H.

Universitaetsklinik fuer innere Medizin III Hämatologie, Internistische Onkologie

Salzburg, Austria

Hanusch Krankenhaus Der Wiener Gebietskrankenkasse

3. Medizinsiche Abteilung

Vienna, Austria

Sponsor: Glaxosmithkline Research & Development Limited

Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.